Cancer research
Researchers at the University of Missouri have made significant progress in developing a new therapeutic approach for brain cancer, utilizing exosomes as a drug delivery system. This innovative method has shown promise in overcoming the blood-brain barrier, ensuring efficient cellular uptake, and ultimately, leading to cytotoxicity in glioblastoma cells. The
Cancer research
Researchers have made new findings on the pathogenesis of human papillomavirus (HPV) and recurrent respiratory papillomatosis (RRP) caused by HPV6/11, and the current treatments and potential new foundations for development of future treatments. The study's findings are based on a comprehensive literature search using PubMed and Google
Cancer research
Researchers at the University of Texas MD Anderson Cancer Center have published a new report on the use of bezlotoxumab, a monoclonal antibody, in treating recurrent clostridioides difficile (CDI) infection in pediatric stem cell transplant (SCT) patients. The study found that bezlotoxumab, when used in conjunction with antibiotic therapy, was
Cancer research
Researchers have emphasized the importance of developing prognostic and predictive biomarkers to improve patient selection in lung cancer treatment. This research, conducted at Maastricht University Medical Center, highlights the need for more effective strategies in managing the disease. Key Takeaways: * Lung cancer is the leading cause of cancer-related death worldwide,
Cancer research
Researchers at Hubei Cancer Hospital have initiated a clinical trial aimed at reversing resistance to first-line PD(L)-1 monoclonal antibody combination therapy in stage IV non-small cell lung cancer patients with negative driver genes. The trial, registered with the Chinese Clinical Trial Registry (ChiCTR), seeks to explore the efficacy
Cancer research
Researchers at the Third Affiliated Hospital of Kunming Medical University in Yunnan, China, have conducted a study to evaluate the accuracy and acceptability of self-sampling samples for HPV testing in cervical cancer screening. The study involved 3,000 women aged 17-69 who provided self-sampling vaginal samples alongside provider-sampling samples for
Cancer research
Researchers from Fudan University have explored the use of DNA nanostructures-based materials to improve the therapeutic efficacy of cancer immunotherapy. The study aims to address the challenges of low drug loading, imprecise targeting, and non-specific releasing in current cancer treatments. The researchers designed a DNA nanostructure-based delivery system that can
Cancer research
Researchers at Chongqing Medical University in China have made significant advancements in the field of cancer immunotherapy. According to a recent study published in the Journal for ImmunoTherapy of Cancer, investigators have discovered that shared neoantigens, including KRAS, TP53, and PIK3CA mutations, have substantial immunogenicity and offer promising therapeutic potential
Cancer research
A new research study published in Aggregate journal presents a promising approach to overcome current limitations in immune checkpoint blockade (ICB) therapies for treating oral squamous cell carcinoma (OSCC). The researchers from Sichuan Cancer Hospital & Institute developed an immunostimulatory nanovaccine using tetrahedral framework nucleic acids (tFNAs) as a carrier
Cancer research
Shanghai Pudong Hospital has listed a Phase 2 clinical trial for patients with MSS/pMMR colorectal cancer, a type of cancer that has failed first-line treatment. The trial involves a collaboration with Shanghai Junshi Bioscience Co., Ltd. and will enroll 32 patients from the USA. The trial aims to assess
Cancer research
Asan Medical Center, a major hospital in South Korea, has registered a clinical trial with the Clinical Research Information Service (CRiS) for the development of a patient-tailored prostate cancer diagnostic protocol using magnetic resonance imaging (MRI) and biomarkers. The study aims to reduce unnecessary biopsies, enhance high-risk prostate cancer detection,
Cancer research
A new study has found that a proportion of men with low-risk prostate cancer, specifically grade group 1 (GG1), have a higher-risk disease than previously suggested by biopsy. The study, published in JAMA Oncology, used data from over 117,000 men with localized GG1 prostate cancer and found that 60%
